US 11,702,483 B2
Method of treating an NME7 expressing cancer with a peptide
Cynthia Bamdad, Waltham, MA (US); and Benoit Smagghe, Waltham, MA (US)
Assigned to MINERVA BIOTECHNOLOGIES CORPORATION, Waltham, MA (US)
Filed by MINERVA BIOTECHNOLOGIES CORPORATION, Waltham, MA (US)
Filed on Aug. 24, 2018, as Appl. No. 16/111,894.
Application 16/111,894 is a division of application No. 15/302,461, abandoned, previously published as PCT/US2015/024764, filed on Apr. 7, 2015.
Application 15/302,461 is a continuation in part of application No. PCT/US2014/061821, filed on Oct. 22, 2014.
Application PCT/US2014/061821 is a continuation in part of application No. PCT/US2014/050773, filed on Aug. 12, 2014.
Claims priority of provisional application 62/127,746, filed on Mar. 3, 2015.
Claims priority of provisional application 62/114,526, filed on Feb. 10, 2015.
Claims priority of provisional application 61/976,390, filed on Apr. 7, 2014.
Prior Publication US 2019/0031779 A1, Jan. 31, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/40 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01); C07K 16/32 (2006.01)
CPC C07K 16/40 (2013.01) [A61K 39/0011 (2013.01); C07K 16/30 (2013.01); C07K 16/3092 (2013.01); C07K 16/32 (2013.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C12N 2800/22 (2013.01)] 7 Claims
 
1. A method of treating a nucleoside diphosphate protein kinase 7 (NME7) expressing cancer in a subject, the method comprising administering to the subject a composition, wherein the composition comprises a peptide comprising the amino acid sequence of SEQ ID NO:145.